Inhibiting macrophages by CSF-1 receptor blockage led to CNS lymphoma progression, reduced T-cell infiltration and blocked rituximab efficacy, showing the important role of tumour-associated macrophages in the CNS lymphoma TME, like in the other tumours [143]. The gene discussed is CSF1R; the disease is primary central nervous system lymphoma.